Solas BioVentures
Venture capitalChattanooga · Pre-Seed–Series B · 16 people tracked
Investment thesis
Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biopharmaceuticals, medical devices, and digital health. The firm takes a founder-centric approach aimed at enabling breakthrough medicine and meaningful technological innovation. Its investment team brings together expertise across medicine, biotechnology, operations, and finance, supported by a network of limited partners who add domain knowledge when evaluating opportunities. The firm frames its work at the intersection of medicine, science, and finance, backing founders it describes as visionaries, contrarians, entrepreneurs, doctors, scientists, lawyers, and financiers who aim to transform the standard of care and improve patient outcomes.
Source: firm website, verified Aug 25, 2026.
Team · 16 people
from the firm's website & curated & public directories
Founder mafia
3 people who came through Solas BioVentures went on to found or lead other companies.
What they invest in
from 27 of 30 portfolio companiesHealthtech ×24Medical Devices ×19Biotech ×14Digital Health ×10AI & Machine Learning ×5Hardware ×5Deep Tech ×3FemTech ×2
HQs:United States×20
Who they back
founder profiles across 13 portfolio companiesFounding team size:solo founder×72 founders×54+ founders×1
Investments · 30 tracked
founders shown can be your intro pathBy year:2026 · 12022 · 12021 · 32020 · 12019 · 17 dated
Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19.
BiotechHealthtech
Co-investorsAdvent Life Sciences
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.
BiotechHealthtechHouston, US
David J. Tweardy(Executive Officer, Director)Ronald DePinho(Director)
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)Jim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)Allen Meacham(President and Chief Executive Officer)Brad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)
Co-investorsFresenius Medical Care Ventures
Chapel Hill, US
Board seatTravis Manasco· per SEC Form D · $4M raise · filed Oct 2021
Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System.
BiotechDigital HealthHealthtechMedical DevicesMaple Grove, US
Michael Hoey(Founder)inMichael Kujak(Executive Officer, Director)Christopher Dixon(Chief Medical Officer)
BoardAndrew Cleeland(Director)Jan Garfinkle(Director)inDavid Adair(Director)in
Board seatMichael Hoey· per SEC Form D
Co-investorsArboretum Ventures
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation.
BiotechHealthtechMedical Devices
Paul J. Fitzpatrick(Chief Executive Officer)
Co-investorsChattanooga Renaissance FundInnova Memphis, Inc.
Co-investorsBioBrit
Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsScientific Health Development
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.
BiotechMedical Devices
Co-investorsOrlando Health VenturesRex Health Ventures
Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients.
HardwareHealthtechMedical Devices
Eric Leuthardt(Chief Executive Officer & Founder)inJenna Gorlewicz(Chief Technology Officer & Founder)inAnna Huguenard(Chief Medical Officer & Founder)inJesse Wheeler(Chief Operations Officer)inRyan Kight(Chief Financial Officer)in
Co-investorsKaleida CapitalDeep Future
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.
BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Vamsee Pamula(Executive Officer, Director)inRichard M. West(Executive Officer, Director)in
BoardDennis Sacha(Director)William A. Hawkins(Director)
Co-investorsDuke Capital PartnersIAG Capital PartnersRex Health VenturesVentureSouth
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.
BiotechDigital HealthHealthtechMedical DevicesCary, US
Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)inRichard Shea(Executive Officer, Director, Promoter)in
BoardHannah Chang(Director)Aiden Aceves(Director)in
Co-investorsARCH Venture PartnersInsight PartnersBroadview VenturesRev1 VenturesRTW Investments L.P.
HealthtechWestminster, US
Donald Conty(Executive Officer, Director, Promoter)Jerome Edwards(Executive Officer, Director, Promoter)
BoardThomas Kurian(Director, Promoter)
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways.
BiotechHealthtechMedical DevicesArden Hills, US
Laura Stoltenberg(Executive Officer, Director)
BoardDavid Belitz(Director)inDoug French(Director)James Eadie(Director)Donald Gonzales(Founder and Chief Medical Officer)
Co-investorsBrightstone Venture Capital
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)Ramille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)
BoardRima Chakrabarti(Director)in
Co-investorsBetter Ventures Central LlcLofty VenturesPathway BioventuresPortal InnovationsKdT Ventures
EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSChattanooga, US
Ryan Seaberg(Co-Founder)Tyler Seaberg(Executive Officer, Director, Promoter)Robert Newman(Executive Officer, Director, Promoter)
Co-investorsAtlanta Technology AngelsChain Reaction
Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions.
Digital HealthHardwareMedical DevicesKnoxville, US
Ryan Wilemsen(Executive Officer)Stephen Grady Arnold(Executive Officer)Britton Alan Garrett(Executive Officer, Director)John Green(Executive Officer)Britton Garrett(Executive Officer, Director)Brent Laing(Executive Officer, Director)
Co-investorsJumpstart Capital
Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms.
HardwareHealthtechMedical DevicesFridley, US
Harlan Lee Sorkin(Executive Officer, Director)Gil M. Vardi(Director)
BoardDenis Harrington(Director)David Adair(Director)Jim Bullock(Director)
Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOxford, US
Jeffrey June(Executive Officer, Director)Teresa June(Executive Officer)
Co-investorsBroadview Ventures
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.
BiotechHealthtech
Co-investorsLongitude CapitalProspect Venture PartnersRex Health Ventures
Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022.
BiotechHealthtechPittsburgh, US
Thomas V. Petzinger, Jr.(LLC Manager)Michael E. Bozik(LLC Manager)Steven Dworetzky(Executive Officer)
BoardBenjamin A. Gomez(LLC Manager)Jeffrey S. McCormick(LLC Manager)inGregory T. Hebrank(LLC Manager)
Co-investorsSaturn Partners
NX Prenatal is a molecular diagnostics company developing exosome-based liquid biopsy assays that detect adverse pregnancy conditions such as preterm birth, preeclampsia, and placenta accreta.
BiotechDigital HealthFemTechHealthtechLouisville, US
GAIL PAGE(Executive Officer, Director)BRIAN BROHMAN(Executive Officer, Director)ROBERT SAUNDERS(Director)KEVIN BRAMER(Director)ALAN MACK(Director)
Co-investorsBelle Impact FundMindshift CapitalGolden SeedsPortfolia
Olympus develops medical technologies and solutions for detecting and treating disease.
HardwareHealthtechMedical Devices
Pathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries.
AI & Machine LearningHealthtechMedical Devices
Co-investorsInnoventures IowaNext Level Ventures
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.
AI & Machine LearningDigital HealthHealthtechPlymouth, US
Brian D. Athey(Co-founder)Daniel Jasewicz(Company Leadership (Strategy & Commercialization))inGerry Higgins(Scientific Strategy Lead)inAlex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)
PreTel develops wearable uterine electromyography sensors and AI-powered analysis software to monitor uterine contractions during pregnancy, enabling early detection of preterm labor, assessment of false labor, and guided Pitocin dosing during labor induction for obstetric care providers.
AI & Machine LearningFemTechMedical DevicesChattanooga, US
Roger Young(Chief Medical Officer / Founder)Marc Finch(CEO)
BoardMark A Samuels(Chairman)
Co-investorsTech Square Ventures
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US
Chris Villongco(Head of Technology / CTO)inRob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)Robert J. Krummen(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioShionogiOTC: SGIOFTvardi TherapeuticsNASDAQ: TVRD
Portfolio news
latest coverage across their companiesAurenar · stlmag.com · Aug 19, 2026
Basking Biosciences · insightpartners.com · Jan 21, 2026
Frequently asked questions
- How many investments has Solas BioVentures made?
- Solas BioVentures has 31 tracked investments.
- What stage does Solas BioVentures invest at?
- Solas BioVentures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Solas BioVentures focus on?
- Solas BioVentures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Solas BioVentures located?
- Solas BioVentures is headquartered in Chattanooga, US.
- Who does Solas BioVentures co-invest with?
- Solas BioVentures most often shares deals with Longitude Capital, Angel Physicians Fund, Broadview Ventures, among 53 tracked co-investors.
Images
Co-investors · 1
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Firms observed investing alongside Solas BioVentures, from public investor directories. Shared companies are the overlap with Solas BioVentures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Lang Sheng Investment (朗盛投资) is a leading Chinese investment firm focused on the large healthcare sector, with experience in screening, investing in, and supporting medical and health companies.